$91 Million

NantHealth

Initial Public Offering

Bookrunner, June 2016

NantHealth is a next-generation, evidence-based, personalized healthcare company applying novel diagnostics tailored to the specific molecular profiles of patient tissues, integrated clinically with large-scale real-time biometric signal and phenotypical data, resulting in safer and more effective treatment decisions for critical illnesses. The Company’s comprehensive systems-based approach consists of a highly differentiated model for the delivery of healthcare, enabled by its unique global software and hardware systems infrastructure that integrates vast amounts of patient, management, bioinformatics, molecular medicine and clinical practice data from both traditional and novel sources. As a pioneer in the era of big data and augmented intelligence, the Company is seeking a fundamental change in healthcare to enable value-based care and evidence-based clinical practice.